Rchr
J-GLOBAL ID：201301099220367387   Update date: Mar. 05, 2024

Ueda Koki

ウエダ コウキ | Ueda Koki
Affiliation and department：
The University of Tokyo

About The University of Tokyo


Homepage URL  (1)： http://kaken.nii.ac.jp/d/r/80632190.ja.html
Research field  (2)： Tumor biology ,  Hematology and oncology
Research keywords  (5)： pre-leukemia stem cell ,  clonal hematopoiesis ,  myeloproliferative neoplasms ,  leukemia stem cell ,  acute myeloid leukemia
Research theme for competitive and other funds  (10)：
  • 2023 - 2026 心不全におけるクローン性造血の包括的理解とエクソソームを介した治療応用
  • 2022 - 2025 DNAメチル化を基軸とした炎症ストレスとクローン性造血の相互的役割の解明
  • 2021 - 2024 骨髄増殖性腫瘍が急性白血病に転化する機序と予防的治療法の解明
  • 2016 - 2018 The role of HMGA2 in the pathogenesis of MPN
  • 2015 - 2018 Development of novel diagnostics and treatments using HMGA2 mRNA in patients with myeloproliferative neoplasms
Show all
Papers (43)：
  • Takahiro Sano, Koki Ueda, Keiji Minakawa, Tsutomu Mori, Yuko Hashimoto, Haruhiko Koseki, Yasuchika Takeishi, Kazuhiko Ikeda, Takayuki Ikezoe. Impaired Repopulating Ability of Uhrf2-/- Hematopoietic Progenitor Cells in Mice. Genes. 2023
  • Koki Ueda. Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies. Experimental Hematology. 2023
  • Kazuhiko Ikeda, Koki Ueda. Gaining MOMENTUM against anaemic myelofibrosis. Lancet (London, England). 2023. 401. 10373. 248-249
  • Keiji Minakawa, Satoshi Ono, Mao Watanabe, Yuka Sato, Saki Suzuki, Shou Odawara, Kinuyo Kawabata, Koki Ueda, Kenneth E Nollet, Hideki Sano, et al. Evaluation of a quantitative PCR-based method for chimerism analysis of Japanese donor/recipient pairs. Scientific reports. 2022. 12. 1. 21328-21328
  • Kazuhiko Ikeda, Keiji Minakawa, Kenichi Yamahara, Minami Yamada-Fujiwara, Yoshiki Okuyama, Shin-Ichiro Fujiwara, Rie Yamazaki, Heiwa Kanamori, Tohru Iseki, Tokiko Nagamura-Inoue, et al. Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events. Transfusion. 2022. 62. 6. 1280-1288
ｍore...
MISC (9)：
  • 原田 佳代, 野地 秀義, 深津 真彦, 佐野 隆浩, 植田 航希, 七島 晶子, 木村 哲, 大河原 浩, 池田 和彦, 小川 一英, et al. 単施設における骨髄異形成症候群に関する後方視的検討. 臨床血液. 2017. 58. 9. 1718-1718
  • 深津 真彦, 助川 真純, 七島 晶子, 大河原 浩, 佐野 隆浩, 植田 航希, 木村 哲, 池田 和彦, 野地 秀義, 小川 一英, et al. 腹水貯留を伴う慢性骨髄単球性白血病にアザシチジン・エトポシド併用が奏効した1例. 臨床血液. 2017. 58. 4. 403-403
  • 深津 真彦, 助川 真純, 小川 一英, 斎藤 友紀子, 七島 晶子, 大河原 浩, 佐野 隆浩, 植田 航希, 木村 哲, 池田 和彦, et al. 同種造血幹細胞移植後の肝障害の診断に肝生検が有用であった二次性ヘモクロマトーシスの1例. 臨床血液. 2016. 57. 12. 2607-2607
  • Koki Ueda, Kazuhiko Ikeda, Takayuki Ikezoe, Kazuei Ogawa, Yuko Hashimoto, Kayo Harada-Shirado, Hiroshi Ohkawara, Norio Komatsu, Kotaro Shide, Kazuya Shimoda, et al. HMGA2 Orchestrates the Tumorgenesis of Myeloproliferative Neoplasms (MPN) in Corporation with JAK2V617F. BLOOD. 2016. 128. 22
  • Recent advance of genetic/epigenetic studies and therapeutic strategies in patients with MDS. 2016. 73. 5. 571-579
ｍore...
Education (2)：
  • 2008 - 2012 The University of Tokyo Graduate School of Medicine
  • 1999 - 2005 Fukushima Medical University School of Medicine
Professional career (2)：
  • PhD (東京大学)
  • MD (福島県立医科大学)
Work history (5)：
  • 2021/03 - 現在 Fukushima Medical University Department of Blood Transfusion and Transplantation Medicine Associate Professor
  • 2017/08 - 2021/02 Albert Einstein College of Medicine Department of Cell Biology Research Fellow
  • 2016/05 - 2017/07 Fukushima Medical University
  • 2014/04 - 2016/04 Fukushima Medical University
  • 2012/04 - 2014/03 The University of Tokyo Faculty of Medicine University Hospital
Committee career (1)：
  • 2021/10 - 現在 Japanese Society of Hematology councillor
Awards (5)：
  • 2022/10 - 日本白血病研究基金 一般研究賞
  • 2022/01 - Young Researchers Award
  • 2020/08 - International Society for Experimental Hematology (ISEH) Postdoc Award (Travel Grant) MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia switch mechanism
  • 2011/04 - 日本学術振興会 特別研究員
  • 2009/12 - Japan Adult Leukemia Study Group (JALSG) Young Investigator ASH Travel Award Impact on Survival and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Association Membership(s) (8)：
The Japan Society of Transfusion and Cell Therapy ,  International Society for Experimental Hematology ,  American Society of Hematology ,  Japanse Cancer Association ,  Japanse Society for Transplantation and Cellular Therapy ,  Japanese society of Medical Oncology ,  The Japanese Society of Hematology ,  The Japanese Society of Internal Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM